Skip to content

Transversus Abdominal Plane Block at Total Laparoscopic Hysterectomy: Effect on Quality of Recovery

Randomized Trial of Transversus Abdominal Plane (TAP) Block at Total Laparoscopic Hysterectomy: Effect of Regional Analgesia on Quality of Recovery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01479270
Acronym
TAP
Enrollment
56
Registered
2011-11-24
Start date
2011-05-31
Completion date
2012-01-31
Last updated
2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Pain, Postoperative

Keywords

recovery, postoperative, pain, laparoscopy, hysterectomy, ropivacaine, TAP block, local anesthesia

Brief summary

The Transversus Abdominal Plane (TAP) block has been used with good success to decrease postoperative pain following laparatomy. If the TAP block provides any improvement in the quality of recovery following laparoscopic hysterectomy, it could decrease the need for postoperative narcotics and allow for more outpatient hysterectomy procedures.

Interventions

DRUGTAP Block

Bilateral transversus abdominal plane injection under ultrasound guidance, done at conclusion of hysterectomy procedure, prior to emergence from general anesthesia

Sponsors

MetroHealth Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Any patient undergoing laparoscopic hysterectomy * Age ranges 18-80 * Reading literacy * English speaking * Able to give informed consent

Exclusion criteria

* History of relevant drug allergy * Chronic opioid users who may have tolerance to pain medications * Inability to understand written consent forms or give consent * Age less than 18 or over 80 * Any conversion to open surgery

Design outcomes

Primary

MeasureTime frameDescription
Quality of Recovery Questionnaire (QoR-40) on Postop Day #1 or #2Postop Day #1 or Day #240 question survey completed on paper or by telephone on post-operative day #1 or #2, designed to measure health status after surgery and anesthesia. Scale ranges from 40 (extremely poor qualify of recovery) to 200 (excellent quality of recovery).

Secondary

MeasureTime frameDescription
Narcotic UsePostop Day #0 and Day #1narcotic use in mg of Morphine will be recorded
Visual Analog Scale (VAS) for Pain2 and 24 hours post operativevisual analogue scales for pain will be completed on post-operative day #0 and #1, pain is assessed on a 10-point visual analogue scale (0 = no pain; 1 to 3 = mild; 4 to 6 = moderate pain; 7 to 10 = severe pain.)
Intraoperative Timethe total intraoperative time in minutesThe total time in the operating room will be recorded to see if there is a difference between groups.

Participant flow

Participants by arm

ArmCount
Tap Block
Patients randomized to either Tap Block or No Tap Block
28
No Block
Patients randomized to either Tap Block or No Tap Block
28
Total56

Baseline characteristics

CharacteristicTotalNo BlockTap Block
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
56 Participants28 Participants28 Participants
Sex: Female, Male
Female
56 Participants28 Participants28 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 280 / 28
other
Total, other adverse events
0 / 280 / 28
serious
Total, serious adverse events
0 / 280 / 28

Outcome results

Primary

Quality of Recovery Questionnaire (QoR-40) on Postop Day #1 or #2

40 question survey completed on paper or by telephone on post-operative day #1 or #2, designed to measure health status after surgery and anesthesia. Scale ranges from 40 (extremely poor qualify of recovery) to 200 (excellent quality of recovery).

Time frame: Postop Day #1 or Day #2

ArmMeasureValue (MEDIAN)
TAP BlockQuality of Recovery Questionnaire (QoR-40) on Postop Day #1 or #2168.0 units on a scale
No BlockQuality of Recovery Questionnaire (QoR-40) on Postop Day #1 or #2169.5 units on a scale
Secondary

Intraoperative Time

The total time in the operating room will be recorded to see if there is a difference between groups.

Time frame: the total intraoperative time in minutes

ArmMeasureValue (MEDIAN)
TAP BlockIntraoperative Time47.4 Minutes
No BlockIntraoperative Time34.5 Minutes
Secondary

Narcotic Use

narcotic use in mg of Morphine will be recorded

Time frame: Postop Day #0 and Day #1

ArmMeasureGroupValue (MEDIAN)
TAP BlockNarcotic UsePost operative day #011.7 mg of morphine
TAP BlockNarcotic UsePost operative day #17.5 mg of morphine
No BlockNarcotic UsePost operative day #011.8 mg of morphine
No BlockNarcotic UsePost operative day #19.0 mg of morphine
Secondary

Visual Analog Scale (VAS) for Pain

visual analogue scales for pain will be completed on post-operative day #0 and #1, pain is assessed on a 10-point visual analogue scale (0 = no pain; 1 to 3 = mild; 4 to 6 = moderate pain; 7 to 10 = severe pain.)

Time frame: 2 and 24 hours post operative

ArmMeasureGroupValue (MEDIAN)
TAP BlockVisual Analog Scale (VAS) for Pain2 hours post operative5.0 units on a scale
TAP BlockVisual Analog Scale (VAS) for Pain24 hours post operative5.0 units on a scale
No BlockVisual Analog Scale (VAS) for Pain2 hours post operative6.0 units on a scale
No BlockVisual Analog Scale (VAS) for Pain24 hours post operative5.0 units on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026